Lyle Jackson, MD
Foot and Ankle Surgery · Eugene, ORNPI 1144540790
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (39.6%), education and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Steelhead Surgical Inc at 57.2% of the total. Reporting peaked in 2019 at $2,670 and has fallen 60.2% since, to $1,062 in 2025.
Across 48 payments — averaging $165.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Steelhead Surgical Inc$5K
- Stryker$2K
- Arthrex$1K
- Encore Medical, LP$187
- Wildwood Medical LLC$71
- Restor3d, Inc.$55
- plus $71 from 3 others
Across 6 payments — averaging $1417.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$9K
What the payments were for
- Travel & lodging$3,15640%
- Food & beverage$1,90524%
- Education$2,81335%
- Gifts$881%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Steelhead Surgical Inc | 10 | $4,558 |
| Stryker(2 entities) | 19 | $1,816 |
| Arthrex | 12 | $1,205 |
| Encore Medical, LP | 2 | $187 |
| Wildwood Medical LLC | 1 | $71 |
| Restor3d, Inc. | 1 | $55 |
| Medshape, Inc. | 1 | $35 |
| Sonex Health, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,962 in reported general payments places this provider in the 75th percentile of 113 foot and ankle surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 114 | $1,120 |
| Oxycodone Hcl | 146 | $975 |
| Ondansetron OdtOndansetron | 111 | $672 |
| Meloxicam | 68 | $299 |
| Mupirocin | 29 | $228 |
| Cephalexin | 20 | $227 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $212 |
| Tramadol Hcl | 45 | $170 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Eugene
- Christopher CychoszEugene$8K
- Philip McKinneyEugene$4K
- Thomas YatesEugene$4K
- Drew PearsonEugene$3K
- Jacob GreenEugene$3K
- Natalie MesnierPortland$339K
- Stephen WallaceLake Oswego$205K
- Scott BoyntonPortland$120K
- Andrew ShinabargerPortland$85K
- Cassandra TomczakTualatin$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.